Cactus Acquisition 1 ^{Priced, Nasdaq: CCTS}

We are a newly incorporated Cayman Islands exempted company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. While we may pursue a business combination target in any business or industry and across any geographical region, we intend to focus our search on technology-based healthcare businesses that are domiciled in Israel, that carry out all or a substantial portion of their activities in Israel, or that have some other significant Israeli connection. Our sponsor is a newly formed Delaware limited partnership that was created jointly by three companies/funds that are significant and active participants in the healthcare technology sphere in Israel, upon which we intend to focus in our pursuit of an initial business combination. We believe we will benefit from the deep and broad expertise of our sponsor’s three primary participants in identifying companies with growth and innovation potential and scaling those businesses. Our sponsor’s three primary participants are Clal Biotechnology Industries, Israel Biotech Fund, and Consensus Business Group.